Radical prostatectomy for patients with localized prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Prostate Seminal Vesicles Cell Line, Tumor Pelvis Urethra Rectum Tumor Cells, Cultured Penis Urinary Bladder Fascia Chromosomes, Human, Pair 8 Neoplastic Cells, Circulating Pubic Symphysis Epithelial Cells

Organisms2

Mice, Nude Mice, SCID

Diseases40

Prostatic Neoplasms Urinary Incontinence Erectile Dysfunction Neoplasm Recurrence, Local Prostatic Hyperplasia Adenocarcinoma Prostatic Intraepithelial Neoplasia Disease Progression Neoplasm Invasiveness Prostatic Diseases Neoplasm Metastasis Lymphocele Neoplasms, Hormone-Dependent Carcinoma Postoperative Complications Urination Disorders Bone Neoplasms Blood Loss, Surgical Lymphatic Metastasis Recurrence Genetic Predisposition to Disease Sexual Dysfunction, Physiological Breast Neoplasms Urologic Diseases Neoplasms Neoplasm, Residual Lung Neoplasms Prostatic Neoplasms, Castration-Resistant Ovarian Neoplasms Prostatitis Neoplastic Cells, Circulating Colonic Neoplasms Intraoperative Complications Stomach Neoplasms Urinary Bladder Neoplasms Fecal Incontinence Contracture Cell Transformation, Neoplastic Rectal Fistula Pancreatic Neoplasms

Chemicals and Drugs49

Prostate-Specific Antigen Free Radicals Androgen Antagonists Tumor Markers, Biological Androgens Receptors, Androgen Tosyl Compounds Hydroxyl Radical Antineoplastic Agents, Hormonal Flutamide Anilides Racemases and Epimerases Goserelin Free Radical Scavengers Neoplasm Proteins Leuprolide Glutamate Carboxypeptidase II RNA, Messenger Prostatic Secretory Proteins Antineoplastic Agents Tissue Kallikreins Finasteride Androgen Receptor Antagonists Taxoids Kallikreins PTEN Phosphohydrolase Nitriles Dihydrotestosterone Ki-67 Antigen Estramustine DNA, Neoplasm Antigens, Neoplasm Anticarcinogenic Agents RNA, Neoplasm Metribolone RNA, Small Interfering Oncogene Proteins, Fusion Cancer Vaccines 5-alpha Reductase Inhibitors Tumor Suppressor Protein p53 Testosterone Testosterone Congeners Antineoplastic Agents, Phytogenic Seminal Plasma Proteins Antioxidants Phosphodiesterase 5 Inhibitors Androstenols Glutathione S-Transferase pi 3-Oxo-5-alpha-Steroid 4-Dehydrogenase

Analytical, Diagnostic and Therapeutic Techniques and Equipment102

Prostatectomy Neoplasm Grading Neoplasm Staging Laparoscopy Nomograms Treatment Outcome Prognosis Retrospective Studies Biopsy, Needle Disease-Free Survival Biopsy Follow-Up Studies Transurethral Resection of Prostate Brachytherapy Orchiectomy Predictive Value of Tests Risk Factors Salvage Therapy Immunohistochemistry Early Detection of Cancer Survival Rate Survival Analysis Kaplan-Meier Estimate Multivariate Analysis Cohort Studies Sensitivity and Specificity Risk Assessment Proportional Hazards Models Radiotherapy Combined Modality Therapy Risk Prospective Studies Reverse Transcriptase Polymerase Chain Reaction SEER Program Radiotherapy, Adjuvant Laparoscopes Biopsy, Large-Core Needle Tissue Array Analysis Radiotherapy, Conformal Preoperative Care Surgery, Computer-Assisted Urinary Sphincter, Artificial Preoperative Period Surgical Equipment Tumor Burden Neoadjuvant Therapy Reproducibility of Results Case-Control Studies Digital Rectal Examination Incidence Gene Expression Profiling Numbers Needed To Treat Logistic Models Odds Ratio Xenograft Model Antitumor Assays Urologic Surgical Procedures, Male Lymph Node Excision Incontinence Pads Perioperative Period Neoplasm Transplantation Questionnaires Transplantation, Heterologous Blotting, Western Tissue Embedding Radiotherapy, Intensity-Modulated Radiotherapy Dosage Oligonucleotide Array Sequence Analysis Registries Radiotherapy, Image-Guided ROC Curve Organ Sparing Treatments Treatment Failure Chemotherapy, Adjuvant Postoperative Period Intraoperative Care Postoperative Care Antineoplastic Combined Chemotherapy Protocols Polymerase Chain Reaction Specimen Handling In Situ Hybridization, Fluorescence Cystectomy Immunoenzyme Techniques Operative Time Feasibility Studies Mass Screening Organ Size Electron Spin Resonance Spectroscopy Regression Analysis Transfection Research Design Decision Support Techniques Patient Selection Models, Biological Magnetic Resonance Imaging Probability Pelvimetry Analysis of Variance Chi-Square Distribution Castration Blood Transfusion Models, Statistical Anastomosis, Surgical

Psychiatry and Psychology2

Erectile Dysfunction Learning Curve

Phenomena and Processes34

Nomograms Gene Expression Regulation, Neoplastic Penile Erection Time Factors Sensitivity and Specificity Risk Cell Proliferation Apoptosis Genetic Predisposition to Disease Gene Fusion Odds Ratio DNA Methylation Signal Transduction Chromosomes, Human, Pair 8 Cell Growth Processes Cell Survival Genotype Drug Resistance, Neoplasm Cell Division Down-Regulation Organ Size Dose-Response Relationship, Drug Urination Cell Movement Transfection Probability Up-Regulation Chi-Square Distribution Promoter Regions, Genetic Cell Cycle Polymorphism, Genetic Mutation Oncogene Fusion Algorithms

Disciplines and Occupations5

Robotics Urology Immunohistochemistry General Surgery Research Design

Anthropology, Education, Sociology and Social Phenomena4

Quality of Life Clinical Competence Forecasting National Cancer Institute (U.S.)

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science12

Robotics Survival Rate SEER Program Radiotherapy, Conformal Surgery, Computer-Assisted Incidence Questionnaires Radiotherapy, Intensity-Modulated Registries Decision Support Techniques Databases, Factual Algorithms

Named Groups4

European Continental Ancestry Group African Americans African Continental Ancestry Group Asian Continental Ancestry Group

Health Care49

Watchful Waiting Nomograms Treatment Outcome Retrospective Studies Disease-Free Survival Follow-Up Studies Predictive Value of Tests Risk Factors Survival Rate Survival Analysis Kaplan-Meier Estimate Multivariate Analysis Cohort Studies Sensitivity and Specificity Risk Assessment Proportional Hazards Models Risk Prospective Studies SEER Program Preoperative Care Preoperative Period Reproducibility of Results Age Factors Case-Control Studies Incidence Logistic Models Odds Ratio Perioperative Period Questionnaires Operating Rooms Registries ROC Curve Treatment Failure Postoperative Period Intraoperative Care Postoperative Care Clinical Competence Operative Time Feasibility Studies Mass Screening Regression Analysis Patient Selection Probability Analysis of Variance Chi-Square Distribution Medicare Societies, Medical National Cancer Institute (U.S.)Models, Statistical

Geographicals3

United States Scandinavia Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Prostatectomy Prostatic Neoplasms Prostate Prostate-Specific Antigen Robotics Urinary Incontinence Free Radicals Androgen Antagonists Erectile Dysfunction Neoplasm Grading Neoplasm Recurrence, Local Neoplasm Staging Laparoscopy Watchful Waiting Prostatic Hyperplasia Adenocarcinoma Nomograms Seminal Vesicles Tumor Markers, Biological Treatment Outcome Prostatic Intraepithelial Neoplasia Prognosis Androgens Receptors, Androgen Disease Progression Urology Retrospective Studies Biopsy, Needle Cell Line, Tumor Learning Curve Disease-Free Survival Tosyl Compounds Biopsy Follow-Up Studies Transurethral Resection of Prostate Hydroxyl Radical Antineoplastic Agents, Hormonal Pelvis Brachytherapy Gene Expression Regulation, Neoplastic Orchiectomy Neoplasm Invasiveness Penile Erection Prostatic Diseases Predictive Value of Tests Neoplasm Metastasis Lymphocele Flutamide Risk Factors Neoplasms, Hormone-Dependent Time Factors Salvage Therapy Immunohistochemistry Early Detection of Cancer Anilides Survival Rate Survival Analysis Kaplan-Meier Estimate Multivariate Analysis Urethra Racemases and Epimerases Cohort Studies Sensitivity and Specificity Risk Assessment Goserelin Proportional Hazards Models Radiotherapy Free Radical Scavengers Combined Modality Therapy Risk Prospective Studies United States Mice, Nude Carcinoma Reverse Transcriptase Polymerase Chain Reaction SEER Program Radiotherapy, Adjuvant Laparoscopes Neoplasm Proteins Postoperative Complications Quality of Life Urination Disorders Biopsy, Large-Core Needle Leuprolide Tissue Array Analysis Radiotherapy, Conformal Preoperative Care Surgery, Computer-Assisted Bone Neoplasms Urinary Sphincter, Artificial Preoperative Period Glutamate Carboxypeptidase II Surgical Equipment RNA, Messenger Rectum Blood Loss, Surgical Cell Proliferation Lymphatic Metastasis Prostatic Secretory Proteins Recurrence

No FAQ available that match "radical prostatectomy for patients with localized prostate cancer"